Antwerp, May 12, 2025 (GLOBE NEWSWIRE) — CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMBT”, “CMB.TECH” or “the Company”) will release its first quarter 2025 earnings prior to market opening on Thursday 21 May 2025 and will host a conference call at 8 a.m. EST / 2 p.m. CET to discuss the results for the quarter. The call will be a webcast with an accompanying slideshow. You can find the details of this conference call below and on the “Investor Relations” page of the website. The presentation, recording & transcript will also be available on this page. Webcast Information  Event Type:  Audio webcast with user-controlled slide presentationEvent Date: 21 May 2025Event Time: 8 a.m. EST / 2 p.m. CETEvent Title:  “Q1 2025 Earnings Conference Call”Event Site/URL:   https://events.teams.microsoft.com/event/dffdb414-f685-4c46-b490-dce9f799cbbe@d0b2b045-83aa-4027-8cf2-ea360b91d5e4...

Company Announcement Copenhagen, 12 May 2025 No. 32/2025 ISS A/S reduces treasury shares to less than 5% of share capital In accordance with Section 31 of the Capital Market Act, it is hereby announced that ISS A/S as of today owns a total of 3,087,915 treasury shares of nominally DKK 1, hence less than 5% of the total share capital and the total voting rights in the Company.The decrease in number of treasury shares is a consequence of the share capital reduction resolved by the Company’s Annual General Meeting on 11 April 2024, which was effected today cf. Company announcement no. 31. For investor enquiriesMichael Vitfell-Rasmussen, Head of Group Investor Relations, +45 53 53 87 25 For media enquiriesCharlotte Holm, Head of External Communication, +45 41 76 19 89 ISS is a leading, global provider of workplace and facility service solutions....

Company announcement no. 27 / 2025Schindellegi, Switzerland – 12 May 2025 Trifork Group: Weekly report on share buyback On 28 February 2025, Trifork initiated a share buyback program in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buyback program runs from 4 March 2025 up to and including no later than 30 June 2025. For details, please see company announcement no. 7 of 28 February 2025. Under the share buyback program, Trifork will purchase shares for up to a total of DKK 14.92 million (approximately EUR 2 million). Prior to the launch of the share buyback, Trifork held 256,329 treasury shares, corresponding to 1.3% of the share capital. Under the program, the following transactions have been...

Technip Energies (PARIS:TE) (the “Company”), a global technology & engineering powerhouse leading in energy and decarbonization infrastructure, today announces the launch of a share buy-back program of up to €45 million (the “Share Buy-back Program”) to be used to fulfill the Company’s obligations under equity compensation plans. The maximum number of shares that can be acquired under the Share Buy-back Program is 1.5 million. The Share Buy-back Program is to be carried out until December 31, 2025. The Share Buy-back Program was decided by the Company’s Board of Directors and will be implemented in accordance with the provisions of article 5 of the Market Abuse Regulation (EU) 596/2014 and Commission Delegated Regulation (EU) 2016/1052. The Share Buy-back Program will be carried out pursuant to the authorization to repurchase...

Prosafe has been declared the winner of a bidding process for a four-year contract by Petróleo Brasileiro SA (‘Petrobras’) for the provision of the Safe Notos semi-submersible vessel for safety and maintenance support offshore Brazil. Contract award and timing are subject to a formal process during which Petrobras is under no formal obligation to conclude a contract and other bidders may appeal. A contract, if awarded, has a firm period commitment of four years with the operational commencement in September 2026 closely following on from the expiry of the current Safe Notos contract that commenced in Q3 2022. Total value of the contract is approximately USD 204 million. The Safe Notos is a Dynamically Positioned (DP3) semi-submersible safety and maintenance support (UMS) vessel, capable of operating in harsh environments. The Safe Notos...

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Q1 2025 Qualitative Update: Tecan reports performance in line with expectations and confirms outlook for full year 2025 Männedorf, Switzerland, May 12, 2025 – The Tecan Group (SIX Swiss Exchange: TECN) today provided a qualitative update on its performance for the first quarter of 2025.On March 12, 2025, Tecan indicated a decline in sales in local currencies for the first half of the year. In line with expectations, sales in the first quarter declined within a mid-single-digit percentage range in local currencies. The Life Sciences Business segment delivered a solid performance, with sales in local currencies close to the prior-year level. This development was supported by increased sales into the clinical diagnostics segment, particularly for genomic...

Hepsor AS subsidiary Hepsor 3Torni OÜ signed a real rights contract on April 30, 2025, under which 20 apartments in the Ojakalda Kodud development project (Paldiski mnt 227C, Tallinn) were sold to the company’s other shareholder, Artex KV OÜ. The transaction amount was four million euros, excluding value-added tax. The transaction was carried out under market conditions, and the average price per square meter of the apartments sold corresponded to the pricing level of comparable units previously sold within the same development. Hepsor 3Torni OÜ will continue to sell the remaining 20 apartments owned by the company in accordance with the original development project strategy. Within the framework of the Ojakalda Kodud development project, three apartment buildings with a total of 101 apartments have been completed, of which 61 have already...

SINGAPORE, May 10, 2025 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that the X account of its CEO, Roger Hamilton (X handle: @rogerhamilton), has been compromised. The hackers posted false information without the Company’s knowledge or consent regarding an alleged token launch by the Company. Any posts, solicitations or other messages allegedly announcing this are false and must not be relied upon. The Company and Mr. Hamilton urge the public and all Genius Group investors, partners and customers to disregard all posts and private messages they receive from this account, from yesterday through to when there is affirmative confirmation from the Company’s official accounts (X handles: @GeniusGroupLtd_ and @geniusacademyai)...

MONTREAL, May 10, 2025 (GLOBE NEWSWIRE) — DAVIDsTEA Inc. (TSX-Venture: DTEA) (“DAVIDsTEA” or the “Company”) announces with deep sadness the passing of its founder Herschel Segal in Montreal, Québec on Tuesday, May 6, 2025. Herschel Segal was a pioneering Canadian entrepreneur whose career shaped two iconic retail brands. He was the founder of Le Château, a fashion retailer that became a mainstay in Canadian shopping culture for decades. In 2008, he co-founded DAVIDsTEA, transforming the specialty tea category with a bold, modern retail concept that introduced a new generation to the world of tea. Herschel Segal brought vision, determination, and a strong belief in customer connection to every venture he led. At DAVIDsTEA, he championed accessibility, innovation, and a sense of community — principles that continue to define the...

Analysis of EFX results with AI-based digital pathology underscores the potential value in evaluating histopathology response Data contribute to growing body of support around the anti-fibrotic activity of EFX in patients with pre-cirrhotic MASH SOUTH SAN FRANCISCO, Calif., May 10, 2025 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced results from new analyses of the 96-week Phase 2b HARMONY trial of efruxifermin (EFX) in patients with pre-cirrhotic (F2-F3 fibrosis) metabolic dysfunction-associated steatohepatitis (MASH) in an oral presentation and a poster presentation at the European Association for the Study of the Liver (EASL) Congress 2025 taking place May...